BMC Cardiovascular Disorders · 2024 · 10 citations · 25 references
MedicineNutritionClinical EpidemiologyNutritional EpidemiologyRisk Factor AnalysisCardiovascular DiseaseCardiovascular EpidemiologyCardiovascular RiskDiabetes MellitusCardiovascular Disease PrevalenceCardiovascular Risk MarkersCross-sectional EpidemiologyLogistic RegressionLogistic Regression AnalysisPrevalence EstimationRestricted Cubic Spline ModelsUnivariate Analysis
To assess the correlation between high-sensitivity C-reactive protein (Hs-CRP) and the prevalence of cardiovascular disease (CVD) among individuals with diabetes. A total of 1,555 participants from the National Health and Nutrition Examination Survey were enrolled in this cross-sectional study after excluding individuals without diabetes and those who lacked data on Hs-CRP, diabetes and CVD. All participants were divided into four groups based on quartiles of Hs-CRP: Q1 (≤ 1.20 mg/L), Q2 (1.20–2.86 mg/L), Q3 (2.86–6.40 mg/L), and Q4 (> 6.40 mg/L). Logistic regression analysis, subgroup analysis and restricted cubic spline (RCS) analysis were used to evaluate the correlation between Hs-CRP and the prevalence of CVD in individuals with diabetes. In univariate logistic regression analysis, a higher level of Hs-CRP was associated with a higher prevalence of CVD (P < 0.05). In the multivariate logistic regression analysis adjusting for confounders, the correlation between Hs-CRP and the prevalence of CVD remained significant (Q3 vs. Q1, OR: 1.505, 95% CI: 1.056–2.147, P = 0.024; Q4 vs. Q1, OR: 1.711, 95% CI: 1.171–2.499, P = 0.006; log10(Hs-CRP), OR: 1.504, 95% CI: 1.168–1.935, P = 0.002). Further subgroup analysis showed that a higher Hs-CRP was independently associated with a higher prevalence of CVD in the < 60 years, male, non-hypertension and non-hypercholesterolemia subgroups (P < 0.05). Additionally, RCS analysis revealed a linear positive correlation between Hs-CRP and CVD prevalence (P for nonlinearity = 0.244). A higher level of Hs-CRP was closely related to a higher prevalence of CVD in people with diabetes.
25
Kanyin Liane Ong, Lauryn K Stafford, Susan A. McLaughlin et al. · The Lancet · 2023 · 4.2K citations · Full text
Public Health, Chronic Disease Prevention, Health Sciences +16
Shengjue Xiao, Zhenwei Wang, Ronghua Zuo et al. · Journal of Inflammation Research · 2023 · 124 citations · Full text
Annapurna Kuppa, Himi Tripathi, Ahmed Al‐Darraji et al. · International Journal of Molecular Sciences · 2023 · 106 citations · Full text
Corine den Engelsen, Paula S. Koekkoek, Kees J. Gorter et al. · Cardiovascular Diabetology · 2012 · 86 citations · Full text
Veterinary Medicine, Clinical Sciences, Clinical Nutrition +15